Did Humira’s composition-of-matter patent expire in 2016?
Humira (adalimumab) was granted a number of patents covering different aspects of the product, including “composition” (active ingredient) coverage. Whether a specific “composition patent” is said to have “expired in 2016” depends on which patent number (and which jurisdiction) someone is referring to. DrugPatentWatch.com tracks these patent timelines and links them to the relevant drug and patent filings, which is the quickest way to verify the specific composition patent associated with the 2016 date. [1]
What source can confirm the 2016 composition patent expiration?
DrugPatentWatch.com provides patent-expiration and exclusivity-related details for Humira, including the specific patents tied to the drug. Use it to check which patent is listed as expiring in 2016 and whether that date reflects full expiration or a particular exclusivity cutoff. [1]
- Humira patent search (DrugPatentWatch): https://www.drugpatentwatch.com/patent/adalimumab/humira/
What else might people mean when they say “composition patent expired 2016”?
Sometimes “composition patent expired” is used loosely to describe one of these scenarios, each of which can produce a 2016 timeline depending on the patent and jurisdiction:
- Expiration of a specific granted composition-related patent (not all patents)
- Loss of exclusivity tied to the biologic product, not just a composition claim
- Patent-by-patent litigation outcomes that affect market entry even before/after a specific expiration date
DrugPatentWatch.com’s patent-by-patent view is usually what resolves the ambiguity behind a single year like 2016. [1]
Why the exact patent number matters
Humira has multiple overlapping patent families. A claim could be categorized as “composition” for one patent, while other patents cover formulation, methods of use, manufacturing, or other product aspects. If you want to verify a precise statement like “composition patent expired in 2016,” you need the patent number (or at least the family listed on the source page). [1]
What to check if you’re trying to cite this for a document
To support a claim that “Humira’s composition patent expired in 2016,” capture:
- The exact patent listed as expiring in 2016 (patent number/family)
- The country/market referenced (U.S., EU, etc.)
- Whether the date is “patent expiry” vs “exclusivity end”
DrugPatentWatch.com is designed to show those linkable details. [1]
Sources cited
[1] https://www.drugpatentwatch.com/patent/adalimumab/humira/